The Ministry of Health, Labor and Welfare (MHLW) appears to be ready to begin post-launch drug price adjustments based on cost-effectiveness assessments (CEAs) for the first time since the system was introduced in April 2019. As price tweaks will be…
HOME > TOP STORIES
TOP STORIES
-
REGULATORY Japan to Review Moderna Vaccine with Top Priority, May OK Possible: Minister
March 8, 2021
-
BUSINESS Takeda Submits NDA for Moderna Vaccine in Japan
March 5, 2021
-
REGULATORY Pfizer, Bayer to Pull Plug on “G1” Products with High Generic Erosions
March 5, 2021
-
REGULATORY MHLW Announces New Drug Prices for 1st Off-Year Revision in April
March 5, 2021
-
ORGANIZATION Fast-Track Approval System, New Pricing Rules Needed for Therapeutic Apps: DTx Consortium
March 5, 2021
-
BUSINESS Nichi-Iko Chief Apologizes for GMP Violations, but Draws Clear Distinction from Kobayashi Kako Case
March 4, 2021
-
BUSINESS Takeda to File Moderna Vaccine in Japan This Week
March 4, 2021
-
BUSINESS AbbVie Japan to Boost Immunology Reps as It Gears Up for Rinvoq/Skyrizi Label Expansions
March 3, 2021
-
REGULATORY Nichi-Iko Ordered to Suspend Biz over Sloppy Manufacturing
March 3, 2021
-
REGULATORY Woman Dies 3 Days after COVID-19 Vaccine Shot, but Link Indeterminable
March 3, 2021
-
BUSINESS Iwasaki to Bow Out as Chief of Takeda’s Japan Pharma Biz Unit
March 3, 2021
-
BUSINESS Kyowa Kirin Poised to Speed Up Growth with 5 Strategic Launches, Eyes Blockbuster Potential in Eczema Med
March 2, 2021
-
REGULATORY Nichi-Iko to Get Business Suspension Order on March 3
March 2, 2021
-
BUSINESS Takeda to Offload 4 Diabetes Meds in Japan to Teijin for 133 Billion Yen
March 1, 2021
-
REGULATORY Govt to Deliver 1st COVID-19 Vaccine Dose for 3.7 Million HCPs in April: Minister
March 1, 2021
-
REGULATORY Japan Research Group to Wrap Up Report on Clinical Trials for Cannabis-Derived Drugs by March-End
February 26, 2021
-
BUSINESS Meiji to Discontinue Sale of Kobayashi Kako Products after Biz Suspension
February 26, 2021
-
BUSINESS MSD’s 9-Valent HPV Vaccine Now Available in Japan
February 25, 2021
-
REGULATORY Japan to Start Elderly Vaccine Rollout from April 12: Minister
February 25, 2021
-
BUSINESS Takeda Launches Japan PI/II Trial of Novavax COVID-19 Vaccine
February 25, 2021
ページ
Biogen’s controversial Alzheimer’s drug aducanumab was filed for Japanese regulatory approval in December. If approved, it will be the first…
Japan’s key reimbursement policy panel on December 20 approved an outline of its FY2020 drug pricing reform next April, with…
The Ministry of Health, Labor and Welfare (MHLW) on November 27 added to the NHI price list Japan’s first biosimilars of Avastin (bevacizumab), Nesp (darbepoetin alfa), and Forteo (teriparatide). The NHI prices of first biosimilars are set at 70% of…
Japan will go ahead with the introduction of a cost-effectiveness assessment (CEA) scheme for drugs and medical devices in April…
After decades in recruitment, I say from experience that there’s a particular way to attract candidates to a given role. Do it right, and you’ll have talent chasing you. Get it wrong, and you’ll be left listening to the crickets…